HUM Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
40.9B
+3.1%
39.6B
+22.4%
32.4B
+0.4%
32.2B
-0.4%
32.4B
Cost of Revenue
35.4B
+4.9%
33.7B
+17.4%
28.7B
+2.6%
28.0B
+1.5%
27.6B
Gross Profit
5.5B
-7.5%
5.9B
+62.4%
3.7B
-14.1%
4.3B
-11.7%
4.8B
Operating Expenses
39.5B
+4.3%
37.9B
+13.7%
33.3B
+3.3%
32.2B
+3.1%
31.3B
R&D
SG&A
4.0B
-1.1%
4.0B
-9.3%
4.4B
+8.6%
4.1B
+15.2%
3.5B
Operating Income
1.4B
-22.5%
1.8B
+285.8%
-944000000
-94300.0%
-1000000
-100.1%
1.1B
EBITDA
1.5B
-20.5%
1.9B
+359.7%
-750000000
-469.5%
203.0M
-84.5%
1.3B
Net Income
693.0M
-41.5%
1.2B
+252.6%
-776000000
-500.0%
194.0M
-64.3%
543.0M
EPS (Basic)
$5.78
-41.3%
$9.85
+249.0%
$-6.61
-508.0%
$1.62
-64.2%
$4.52
EPS (Diluted)
$5.73
-41.7%
$9.83
+249.4%
$-6.58
-506.2%
$1.62
-64.1%
$4.51
Shares (Diluted)
121.1M
+0.4%
120.7M
-0.3%
121.0M
+0.2%
120.7M
+0.0%
120.7M
Humana (HUM) — Financials